Lived as an Alzheimer’s patient but was not

The article discusses the importance of accurate diagnosis for Alzheimer’s disease through biomarker testing. It highlights a personal story of a patient initially misdiagnosed with Alzheimer’s who learned the correct diagnosis after additional testing. Experts emphasize that expanding access to FDA-cleared blood biomarker tests, which can identify Alzheimer’s earlier, is crucial, and legislation in Massachusetts aims to ensure insurance coverage for these tests before the legislative session ends.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل